The Pathological Anatomy Research Unit ofUniversità Campus Bio-Medico di Roma organized a seminar on the topic Prosigna Update in breast cancer and nanostring perspective in immuno-oncology for the clinic. The seminar aims to present the most relevant results published and presented during the last oncological congresses in reference to Prosigna™, the diagnostic test (CE/IVD – FDA) which uses the NanoString nCounter ® DX analysis system to evaluate the expression profile of a group of 50 genes implicated in breast cancer progression.
Speakers will be Natalia de la Fuente, PhD Associate Medical Affairs Director and Pascale Morel, Medical Affairs Director, Europe NanoString Technologies.
